[1]Harari D, Tzahar E, Romano J, et al. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase[J]. Oncogene, 1999, 18: 2681-2689. [2]Wang GX, Zhao XY, Meng ZX, et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeos-tasis through attenuation of hepatic lipogenesis[J]. Nat Med, 2014, 20: 1436-1443. [3]Chen Z, Wang GX, Ma SL, et al. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders[J]. Mol Metab, 2017, 6: 863-872. [4]Zhu B, Mei W, Jiao T, et al. Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet[J]. Eur J Pharmacol, 2020, 884: 173350. doi: 10.1016/j.ejphar.2020.173350. [5]Wang H, Wang L, Hu F, et al. Neuregulin-4 attenuates diabetic cardiomyopathy by regulating autophagy via the AMPK/mTOR signalling pathway[J]. Cardiovasc Diabetol, 2022, 21: 205. doi: 10.1186/s12933-022-01643-0. [6]Comas F, Martínez C, Sabater M, et al. Neuregulin 4 is a novel marker of beige adipocyte precursor cells in human adipose tissue[J]. Front Physiol, 2019, 10: 39. doi: 10.3389/fphys.2019.00039. [7]Li Y, Jin L, Jiang F, et al. Mutations of NRG4 contribute to the pathogenesis of nonalcoholic fatty liver disease and related metabolic disorders[J]. Diabetes, 2021, 70: 2213-2224. [8]Díaz-Sáez F, Blanco-Sinfreu C, Archilla-Ortega A, et al. Neuregulin 4 downregulation induces insulin resistance in 3T3-L1 adipocytes through inflammation and autophagic degradation of GLUT4 vesicles[J]. Int J Mol Sci, 2021, 22: 12960. doi: 10.3390/ijms222312960. [9]Zhang L, Bai M, Tang H, et al. Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice[J]. Life Sci, 2019, 217: 185-192. [10]Martínez C, Latorre J, Ortega F, et al. Serum neuregulin 4 is negatively correlated with insulin sensitivity in humans and impairs mitochondrial respiration in HepG2 cells[J]. Front Physiol, 2022, 13: 950791. doi: 10.3389/fphys.2022.950791. [11]Adachi Y, Ueda K, Nomura S, et al. Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling[J]. Nat Commun, 2022, 13: 5117. doi: 10.1038/s41467-022-32658-6. [12]Shi L, Li Y, Xu X, et al. Brown adipose tissue-derived Nrg4 alleviates endothelial inflammation and athero-sclerosis in male mice[J]. Nat Metab, 2022, 4: 1573-1590. [13]Guo L, Zhang P, Chen Z, et al. Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression[J]. J Clin Invest, 2017, 127: 4449-4461. [14]De Munck TJI, Boesch M, Verhaegh P, et al. Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease?[J]. PLoS One, 2021, 16: e0251822. doi: 10.1371/journal.pone.0251822. [15]Tutunchi H, Mobasseri M, Aghamohammadzadeh N, et al. Serum neuregulin 4 (NRG-4) level and non-alcoholic fatty liver disease (NAFLD): a case-control study [J]. Int J Clin Pract, 2021, 75: e14555. doi: 10.1111/ijcp.14555. [16]Cai C, Lin M, Xu Y, et al. Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study[J]. BMC Med, 2016, 14:165. doi: 10.1186/s12916-016-0703-6. [17]Yan P, Xu Y, Wan Q, et al. Plasma neuregulin 4 levels are associated with metabolic syndrome in patients newly diagnosed with type 2 diabetes mellitus[J]. Dis Markers, 2018, 2018: 6974191. doi: 10.1155/2018/6974191. [18]Guo D, Liu J, Zhang P, et al. Adiposity measurements and metabolic syndrome are linked through circulating neuregulin 4 and adipsin levels in obese adults[J]. Front Physiol, 2021, 12: 667330. doi: 10.3389/fphys.2021.667330. [19]Li M, Chen Y, Jiang J, et al. Elevated serum neuregulin 4 levels in patients with hyperthyroidism[J]. Endocr Connect, 2019, 8: 728-735. [20]魏巍, 张旭, 李婉娇, 等. 临床甲亢和亚临床甲亢患者血清Nrg4,TSK水平与血脂、甲状腺激素和基础代谢率的相关性分析[J]. 现代检验医学杂志, 2022, 37: 38-42+47. [21]Li Q, Li C, Jin J, et al. Clinical significance of neuregulin 4, Afamin, and SERPINB1 in gestational diabetes mellitus and their relationship with insulin resistance[J]. Evid Based Complement Alternat Med, 2022, 2022: 2829662. doi: 10.1155/2022/2829662. [22]Kralisch S, Hoffmann A, Kratzsch J, et al. The brown-fat-secreted adipokine neuregulin 4 is decreased in gestational diabetes mellitus[J]. Diabetes Metab, 2018, 44: 150-154. [23]Zhang L, Lu B, Wang W, et al. Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus[J]. Ther Adv Endocrinol Metab, 2021, 12: 20420188211049614. doi: 10.1177/20420188211049614. [24]杨海荣, 丰树菊, 杜鹏琳, 等. 血清Spexin、神经调节蛋白4表达与妊娠期糖尿病的相关性[J]. 广东医学, 2021, 42: 1467-1471. [25]高丽欣, 宋燕, 付凤仙. 妊娠期糖尿病患者血清神经调节蛋白4和Afamin水平变化及临床意义[J]. 中华实用诊断与治疗杂志, 2020, 34: 896-898. |